Get Patent Opposition Report for Ipsen Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Ipsen Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3432916Stabilized Non-Protein Clostridial Toxin CompositionsALLERGANMay 12, 2020
EP3436054Stabilized Non-Protein Clostridial Toxin CompositionsALLERGANMay 12, 2020
EP2692350Lyophilized Preparation Of Botulinum ToxinMEDY TOXFeb 2, 2018

Explore Ipsen Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2957278May 17, 2017A Stable Composition Comprising Pthrp And Uses Thereof2
EP2249847Apr 12, 2017Novel Method For Preparing Extracts Of Ginkgo Biloba1